Autogenic Drainage vs. Mechanical Chest Percussion in Children with Cystic Fibrosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial compares two airway clearance techniques in CF patients: autogenic drainage and mechanical percussion. Participants are randomly assigned to one technique and receive supervised sessions five times a week for six weeks, with assessments of lung function, breathlessness, and quality of life. The study aims to see which method more effectively improves lung function and reduces dyspnea in pediatric CF patients. The trial is conducted at Nishter Hospital Multan, led by Riphah International University. Eligibility includes confirmed CF, age 6-12, and stable condition without recent pulmonary exacerbations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed diagnosis of cystic fibrosis (CF) through a sweat test or genetic testing.
* Age between 6 and 12 years.
* Clinically stable condition (no acute pulmonary exacerbation within the last 4 weeks).

Exclusion Criteria:

* History of thoracic surgery.
* Active hemoptysis.
* Severe physical or cognitive disabilities limiting participation in the intervention or assessments.

Where it's running

• Nishter Hospital Multan
  Multan Khurd, Punjab Province, Pakistan Recruiting

Study contacts

• Principal investigator: Humera Ayub, MS-CPPT — Riphah International University
• Study coordinator: Imran Amjad, PhD
• Email: imran.amjad@riphah.edu.pk
• Phone: 03324390125

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oropharyngeal suction and physiotherapy to detect lung bacteria in kids with chronic lung disease

  A randomized study will test whether taking samples from the throat with suction, with or without prior physiotherapy, can reliably detect bacteria in children 5–18 with chronic lung disease, compared with standard sample methods.

  Recruiting Corporacion Parc Tauli · Sabadell, Barcelona · NCT07903792

• Seeing if CFTR functioncan be restored in CF through patient cells with rare mutations

  This study tests whether testing a patient’s own nasal cells in the lab can predict if CFTR-modulator therapies might help people with uncommon CF mutations.

  Recruiting at 3 sites Istituto Giannina Gaslini · Catania and 2 other locations · NCT07889973

• Perceptions and Intentions Around a Change in CF Treatment

  This study asks adults with cystic fibrosis currently on ETI whether they would switch to VTD if their doctor offered it and what factors influence that decision.

  Recruiting at 6 sites Fondation Ildys · Caen and 11 other locations · NCT07885410

• How the CF medicines elexacaftor, tezacaftor, and ivacaftor behave in the body

  This study tests how the CF medicines elexacaftor, tezacaftor, and ivacaftor move through the body in patients with cystic fibrosis who are already taking the combination therapy.

  Recruiting Phase 4 Istituto Giannina Gaslini · Genova · NCT07809867

• Pharmacokinetics of Antibiotics in CF Patients on ETI

  This study tests how antibiotics behave in the body of people with cystic fibrosis who are taking the ETI modulator therapy and are being treated for a pulmonary infection.

  Recruiting Fondation Ildys · Roscoff · NCT07629986

• Proof of principle for linaclotide to improve gut symptoms in cystic fibrosis

  This will test whether linaclotide can increase intestinal fluid and ease constipation and abdominal symptoms in adults with cystic fibrosis.

  Recruiting Early Phase 1 University of Nottingham · Nottingham · NCT07569419

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.